Valortim
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Valortim, covering 2010-08-10 to 2013-12-09. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects [Phase 1]